JPY 1451.0
(3.5%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.17 Billion | 1.91 Billion | 4.63 Billion | 2.54 Billion | 1.92 Billion | 2.45 Billion |
Net Income | -319 Million | 1.52 Billion | 2.36 Billion | 2.49 Billion | 1.59 Billion | -709.12 Million |
Depreciation & Amortization | 1.32 Billion | 1.47 Billion | 1.11 Billion | 759 Million | 806 Million | 1.18 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 115 Million | -568 Million | 2.08 Billion | 171 Million | -475 Million | 1.49 Billion |
Other non-cash items | 4.75 Billion | -519 Million | -934 Million | -884 Million | -2 Million | 492.18 Million |
Investing Cash Flow | -609 Million | -3.07 Billion | -7.83 Billion | -1.27 Billion | -77 Million | -481.98 Million |
Investments in PPE | -799 Million | -1.35 Billion | -844 Million | -455 Million | -327 Million | -495.32 Million |
Acquisitions | 62 Million | -906 Million | -3.46 Billion | -652 Million | 9 Million | 13.16 Million |
Investment purchases | -6 Million | -817 Million | -3.47 Billion | -122 Million | -85 Million | -67.95 Million |
Sales/Maturities of investments | 138 Million | -835 Million | -778 Million | -444 Million | 333 Million | 12.9 Million |
Other Investing Activities | -2 Million | 840 Million | 727 Million | 398 Million | -7 Million | 55.22 Million |
Financing Cash Flow | -1.72 Billion | -276 Million | 2.08 Billion | 3.34 Billion | -1.5 Billion | -364.39 Million |
Debt repayment | -1.27 Billion | -1.27 Billion | -1.18 Billion | -1.73 Billion | -1.82 Billion | -2.52 Billion |
Dividends payments | - | -333 Million | -322 Million | -184 Million | -129 Million | -119.58 Million |
Common Stock Repurchased | -499 Million | -999 Million | 100 Million | - | - | -157 Thousand |
Common Stock Issuance | 49 Million | 49 Million | 2.98 Billion | 4.96 Billion | 475 Million | 1.01 Billion |
Other Financing Activities | 80 Million | 2.28 Billion | 507 Million | 305 Million | -31 Million | 1.26 Billion |
Accounts receivables | -1.71 Billion | 1.59 Billion | -1.38 Billion | -3.83 Billion | -3.84 Billion | -3.69 Billion |
Accounts payables | 1.65 Billion | -2.03 Billion | 3.53 Billion | 4.25 Billion | 3.75 Billion | 4.61 Billion |
Inventory | 9 Million | -60 Million | 3 Million | -16 Million | 44 Million | -57.25 Million |
Other working capital | 165 Million | -73 Million | -67 Million | -232 Million | -431 Million | 638.46 Million |
Cash at beginning of period | 10.12 Billion | 11.39 Billion | 12.7 Billion | 8.08 Billion | 7.74 Billion | 5.68 Billion |
Cash at end of period | 11 Billion | 10.12 Billion | 11.39 Billion | 12.7 Billion | 8.08 Billion | 7.74 Billion |
Capital Expenditure | -799 Million | -1.35 Billion | -844 Million | -455 Million | -327 Million | -495.32 Million |
Effect of forex changes on cash | 39 Million | 157 Million | 128 Million | -4 Million | -2 Million | 6.62 Million |
Net cash flow / Change in cash | 877 Million | -1.27 Billion | -1.3 Billion | 4.61 Billion | 342 Million | 2.06 Billion |
Free Cash Flow | 2.37 Billion | 564 Million | 3.78 Billion | 2.08 Billion | 1.6 Billion | 1.96 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 244 Million | -1.18 Billion | -319 Million | 352 Million | 277 Million | 232 Million |
Depreciation & Amortization | - | - | 1.32 Billion | 345 Million | 293 Million | 347 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 115 Million | - | - | - |
Other non-cash items | -244 Million | 1.18 Billion | 4.75 Billion | -352 Million | -277 Million | -232 Million |
Investing Cash Flow | - | - | -609 Million | - | - | - |
Investments in PPE | - | - | -799 Million | - | - | - |
Acquisitions | - | - | 62 Million | - | - | - |
Investment purchases | - | - | -6 Million | - | - | - |
Sales/Maturities of investments | - | - | 138 Million | - | - | - |
Other Investing Activities | - | - | -2 Million | - | - | - |
Financing Cash Flow | - | - | -1.72 Billion | - | - | - |
Debt repayment | - | - | -1.27 Billion | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -499 Million | - | - | - |
Common Stock Issuance | - | - | 49 Million | - | - | - |
Other Financing Activities | - | - | 80 Million | - | - | - |
Accounts receivables | - | - | -1.71 Billion | - | - | - |
Accounts payables | - | - | 1.65 Billion | - | - | - |
Inventory | - | - | 9 Million | - | - | - |
Other working capital | - | - | 165 Million | - | - | - |
Cash at beginning of period | - | - | 10.12 Billion | 10.65 Billion | 9.42 Billion | 10.12 Billion |
Cash at end of period | - | - | 11 Billion | 10.78 Billion | 10.65 Billion | 9.42 Billion |
Capital Expenditure | - | - | -799 Million | - | - | - |
Effect of forex changes on cash | - | - | 39 Million | - | - | - |
Net cash flow / Change in cash | - | - | 877 Million | 130 Million | 1.23 Billion | -703 Million |
Free Cash Flow | - | - | 2.37 Billion | 690 Million | 586 Million | 694 Million |
4290
DMED
EPIT
BYDIF
5483
VKAL